In connection with the Transaction, on October 3, 2023, the Histogen Inc. and Allergan mutually elected to terminate the Amended and Restated License Agreement by and between the Company and Allergan (as assigned to Allergan by Suneva Medical Inc. (?Suneva?), dated December 16, 2013, as amended from time to time and the Amended and Restated Supply Agreement by and between the Company and Allergan (as assigned to Allergan by Suneva), dated December 16, 2013, as amended from time to time.